Motility & Functional GI · Article 126

How Should Bile Acid Diarrhea Be Diagnosed?

Bile acid diarrhea requires a structured, evidence-based clinical approach. This review summarizes the key diagnostic, management, monitoring and decision points for gastroenterology and hepatology practice.

Bile acid diarrhea clinical reference — Related free clinical resource: Clinical Pharmacology.

Bile acid diarrhea: practical clinical approach

This page focuses on Bile acid diarrhea with emphasis on decisions that change patient care, common pitfalls, and the current evidence base.

External guidance for Bile acid diarrhea

Clinical takeaway: For Bile acid diarrhea, decisions should integrate current guidelines, patient-specific risk, and the evidence summarized below.

Answer first: Bile acid diarrhea (BAD) should be considered in chronic watery diarrhea, especially after terminal ileal disease/resection, cholecystectomy or abdominal radiotherapy, and in patients labeled as IBS-D or functional diarrhea. Objective testing is preferred where available. SeHCAT retention testing is widely used in some countries; fasting serum 7alpha-hydroxy-4-cholesten-3-one (C4) is another useful marker. FGF19 and fecal bile acid testing are available in selected settings. Symptoms alone cannot reliably diagnose BAD.

Recognize the high-risk contexts

Ileal Crohn’s disease or resection causes secondary BAD; idiopathic bile-acid overproduction can occur without structural ileal disease. Cholecystectomy is another common clinical clue.

Testing varies by country

SeHCAT is unavailable in the United States but widely used elsewhere. Serum C4 is increasingly used as a biochemical surrogate. Quantitative fecal bile acid testing may be available in specialized centers.

Differentiate from other watery-diarrhea causes

Microscopic colitis, celiac disease, medication effects, infection and inflammatory bowel disease may mimic BAD. A positive BAD test does not excuse an incomplete chronic-diarrhea assessment when alarm features are present.

Practical clinical algorithm

Identify risk factors and watery-diarrhea phenotype.
Exclude alarm features and major competing diagnoses.
Use SeHCAT where available or serum C4/validated local testing.
If testing is unavailable, consider a carefully monitored therapeutic trial in an appropriate patient.
Reassess nonresponders rather than simply escalating sequestrant doses.

Common mistakes to avoid

Diagnosing BAD from urgency alone.
Assuming all post-cholecystectomy diarrhea is BAD.
Using a therapeutic response as perfect diagnostic proof.
Ignoring extensive ileal resection, where sequestrants can worsen steatorrhea.
Failing to consider microscopic colitis or celiac disease.

Trainee takeaway

BAD is common and underrecognized; the key is to think of it early and use objective testing when the health system provides it.

Frequently asked questions

How common is BAD in IBS-D?

A substantial minority of patients labeled IBS-D may have bile-acid abnormalities.

What is SeHCAT?

A nuclear-medicine retention test used to quantify bile-acid loss in countries where it is available.

Can serum C4 help?

Yes. Elevated fasting C4 supports increased bile-acid synthesis and can aid diagnosis.

References

1. Thomson ABR. Practice Review in Gastroenterology. CAPstone Academic Publishers; 2014.

2. Thomson ABR. First Principles of Gastroenterology and Hepatology in Adults and Children. Vol II. CAPstone Academic Publishers; 2013.

3. Sadowski DC, Camilleri M, Chey WD, et al. Canadian Association of Gastroenterology Clinical Practice Guideline on the Management of Bile Acid Diarrhea. J Can Assoc Gastroenterol. 2020;3:e10-e27.

4. Arasaradnam RP, Brown S, Forbes A, et al. Guidelines for the investigation of chronic diarrhoea in adults. Gut. 2018;67:1380-1399.

Educational content only. Clinical decisions should incorporate the individual patient, local resources, product labeling, and the most current applicable guideline or regulatory information.

← Back to Clinical Questions